Assessment of cardiorespiratory fitness

OTHER2 trials

Sponsors

Virginia Commonwealth University, I.M. Sechenov First Moscow State Medical University

Conditions

Diabetes Mellitus, Type 2Exercise ToleranceHeart Failure, SystolicHypoxia, AltitudeMetabolic DisturbanceQuality of Life

Unknown Phase

SGLT2 Inhibition in Diabetes and Heart Failure

CompletedNCT02862067

Virginia Commonwealth UniversityDiabetes Mellitus, Type 2, Heart Failure, Systolic

Start: 2016-07-31End: 2018-01-16Updated: 2018-07-16

Direct and Cross Effects of Adaptation to Systemic Hyperthermia: Impact on Quality of Life, Neurohormonal and Psychophysiological Human Status

CompletedNCT04089410

I.M. Sechenov First Moscow State Medical UniversityExercise Tolerance, Hypoxia, Altitude, Metabolic Disturbance +1

Start: 2019-01-14End: 2019-12-27Updated: 2020-11-17

Related Papers

Does dapagliflozin regress left ventricular hypertrophy in patients with type 2 diabetes? A prospective, double-blind, randomised, placebo-controlled study.

2017-08-2323 citations